miR-199a-5p inhibits monocyte/macrophage differentiation by targeting the activin A type 1B receptor gene and finally reducing C/EBPα expression

J Leukoc Biol. 2014 Dec;96(6):1023-35. doi: 10.1189/jlb.1A0514-240R. Epub 2014 Sep 25.

Abstract

miRNAs are short, noncoding RNAs that regulate expression of target genes at post-transcriptional levels and function in many important cellular processes, including differentiation, proliferation, etc. In this study, we observed down-regulation of miR-199a-5p during monocyte/macrophage differentiation of HL-60 and THP-1 cells, as well as human CD34(+) HSPCs. This down-regulation of miR-199a-5p resulted from the up-regulation of PU.1 that was demonstrated to regulate transcription of the miR-199a-2 gene negatively. Overexpression of miR-199a-5p by miR-199a-5p mimic transfection or lentivirus-mediated gene transfer significantly inhibited monocyte/macrophage differentiation of the cell lines or HSPCs. The mRNA encoding an ACVR1B was identified as a direct target of miR-199a-5p. Gradually increased ACVR1B expression level was detected during monocyte/macrophage differentiation of the leukemic cell lines and HSPCs, and knockdown of ACVR1B resulted in inhibition of monocyte/macrophage differentiation of HL-60 and THP-1 cells, which suggested that ACVR1B functions as a positive regulator of monocyte/macrophage differentiation. We demonstrated that miR-199a-5p overexpression or ACVR1B knockdown promoted proliferation of THP-1 cells through increasing phosphorylation of Rb. We also demonstrated that the down-regulation of ACVR1B reduced p-Smad2/3, which resulted in decreased expression of C/EBPα, a key regulator of monocyte/macrophage differentiation, and finally, inhibited monocyte/macrophage differentiation.

Keywords: PU.1; TGF-β signaling pathway; cell proliferation and cell cycle; phosphorylation of Smad2/3.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Activin Receptors, Type I / antagonists & inhibitors
  • Activin Receptors, Type I / genetics
  • Activin Receptors, Type I / physiology*
  • CCAAT-Enhancer-Binding Protein-alpha / biosynthesis
  • CCAAT-Enhancer-Binding Protein-alpha / genetics
  • CCAAT-Enhancer-Binding Protein-alpha / physiology*
  • Cell Line, Tumor
  • Cells, Cultured
  • Colony-Forming Units Assay
  • Fetal Blood / cytology
  • Gene Expression Regulation, Developmental / drug effects*
  • Genes, Reporter
  • HL-60 Cells
  • Hematopoiesis / genetics*
  • Hematopoietic Stem Cells / cytology
  • Humans
  • Macrophages / cytology*
  • MicroRNAs / physiology*
  • Monocytes / cytology*
  • Neoplasm Proteins / metabolism
  • Phosphorylation
  • Protein Processing, Post-Translational
  • Proto-Oncogene Proteins / physiology
  • RNA Interference
  • RNA, Small Interfering / pharmacology
  • Retinoblastoma Protein / metabolism
  • Smad2 Protein / physiology
  • Trans-Activators / physiology
  • Transduction, Genetic
  • Transfection

Substances

  • CCAAT-Enhancer-Binding Protein-alpha
  • MicroRNAs
  • Neoplasm Proteins
  • Proto-Oncogene Proteins
  • RNA, Small Interfering
  • Retinoblastoma Protein
  • SMAD2 protein, human
  • Smad2 Protein
  • Trans-Activators
  • mirn199 microRNA, human
  • proto-oncogene protein Spi-1
  • ACVR1B protein, human
  • Activin Receptors, Type I